News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 3738
- Sources here
- 13
- Companies here
- 25
Active search
3738 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Perceptive Advisors (NVNO) reports 3.5% beneficial stake via 24,605 warrants
Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 3.5% in enVVeno Medical Corporation (NVNO) through 24,605 exercisable warrants. This stake represents 24,605 shares of common stock, based on 682,722 shares outstanding as of July …
Modular Medical, Inc. Q1 FY2027: Net loss $(6.49M), EPS $(1.19) — 10-Q Summary
Modular Medical, Inc. (MODD) reported a net loss of $(6.49M) for Q1 FY2027, an improvement from the prior year, with diluted loss per share at $(1.19). The company's cash and cash equivalents significantly decreased, leading to a flagged going-concern risk due to liquidity issues. …
ENvue Medical, Inc. SEC Filing (Aug 14, 2026)
ENvue Medical, Inc. has filed a Form 12b-25 Notification of Late Filing for its Quarterly Report on Form 10-Q for the period ended June 30, 2026. The company stated that additional time is needed to prepare, compile, and analyze supporting documentation to complete its …
Fuller & Thaler boosts disclosure of 5.19% ICU Medical (ICUI) ownership stake
Fuller & Thaler Asset Management, Inc. has filed an amended Schedule 13G, disclosing a 5.19% beneficial ownership stake in ICU Medical (ICUI). The firm holds 1,298,126.96 shares, with sole voting power over 1,276,819.96 shares and sole dispositive power over all 1,298,126.96 shares. The filing, …
Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard
Adagio Medical Holdings (ADGM) received a Nasdaq deficiency notice on August 13, 2026, for failing to meet the Listing Rule 5550(b)(1) requirement of at least $2.5 million in stockholders' equity, as their June 30, 2026 Form 10-Q reported equity of $(415,000). The notice does …
IceCure Medical (ICCM) expands 2024 employee share incentive reserve
IceCure Medical Ltd. has increased the ordinary shares reserved for its 2024 Employee Equity Incentive Plan by 2,500,000, bringing the new total to 2,612,667 ordinary shares. This expansion, approved by the board on August 11, 2026, provides additional capacity for future equity awards to …
Mobia Medical (MOBI) gets 11.1% ownership filing from Green Park & Golf group
Green Park & Golf Ventures II, LLC and affiliated entities have reported a beneficial ownership of 11.1% in Mobia Medical, Inc. (MOBI), totaling 3,684,409 shares. This stake is held across numerous LLCs, with managers Clay M. Heighten, MD, Carl D. Soderstrom, and Gilbert G. …
Medifast (MED): Citadel entities and Kenneth Griffin disclose sub‑5% ownership stake
Citadel entities, including Citadel Securities LLC and Citadel Advisors LLC, along with Kenneth Griffin, have filed an amended Schedule 13G disclosing beneficial ownership of Medifast (MED) common stock. The filing indicates that each reporting person holds less than 5% of Medifast's outstanding shares, with …
Profound Medical CFO Steps Down; Controller Takes Interim Role
Profound Medical (NASDAQ: PROF; TSX: PRN) has announced a management change, with Matthew Sobczyk, formerly Corporate Controller, promoted to Interim Chief Financial Officer. He succeeds Rashed Dewan, who has stepped down but will remain on a short-term consulting contract to ensure a smooth transition. …
Baker Bros. Advisors (RVMD) discloses 11.4M-share position in Revolution Medicines
Baker Bros. Advisors LP and related entities have reported a passive ownership stake of 5.3% in Revolution Medicines, Inc. This translates to beneficial ownership of 11,443,357 shares of common stock, held through investment funds Baker Brothers Life Sciences, L.P. and 667, L.P. The filing …
Parabilis Medicines (PBLS): ARCH Venture group discloses 6.4M-share, 5.3% ownership
ARCH Venture Fund XII and related entities have disclosed a 5.3% beneficial ownership stake in Parabilis Medicines (PBLS), amounting to 6,412,780 shares of common stock. This Schedule 13G filing indicates a passive investment, with ARCH Venture Partners XII, L.P., ARCH Venture Partners XII, LLC, …
Kestra Medical Technologies (KMTS) Nears Its Fair Value, Is The Stock Already Fully Valued?
Kestra Medical Technologies (KMTS) has seen recent positive share price momentum, with its stock closing at US$27.74. While a common narrative suggests the stock is undervalued with a fair value of $28 based on ambitious growth assumptions, other metrics like the P/S ratio indicate …
National CineMedia (NCMI): Orbis and Allan Gray disclose 9.9% beneficial stake in amended 13G
Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed an amended 13G filing for National CineMedia, Inc. (NCMI), reporting a combined beneficial ownership of 9.9% of the company's common stock, totaling 9,313,977 shares. Orbis holds sole voting and dispositive power …
Praxis Precision Medicines (PRAX): Orbis, Allan Gray disclose 5.5% ownership stake
Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed a 5.5% ownership stake in Praxis Precision Medicines (PRAX), amounting to 1,529,788 shares of common stock as of June 30, 2026. Orbis holds the majority with 1,526,680 shares, while Allan Gray …
(PRAX) and the Role of Price-Sensitive Allocations
This article provides a detailed AI-driven analysis of Praxis Precision Medicines Inc. (NASDAQ: PRAX), highlighting a strong overweight bias across all time horizons. It outlines specific institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report …
TransMedics Group, Inc. Investor News: Rosen Law Firm
The Rosen Law Firm has announced an investigation into potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). The firm is encouraging shareholders of TransMedics Group to visit its website or contact them for more information regarding …
Susquehanna group reports 5.3% Medifast (MED) ownership in Schedule 13G
Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC have collectively reported a 5.3% beneficial ownership stake in Medifast (MED) through a Schedule 13G filing. This amounts to 587,214 shares of Medifast common stock as of June 30, 2026, including options for 542,700 shares held …
Brandes Investment Partners reports 14.9% Utah Medical Products (UTMD) stake
Brandes Investment Partners has filed an amended Schedule 13G, disclosing a 14.92% passive ownership stake in Utah Medical Products Inc., totaling 475,158 common shares. These shares are held across mutual funds and other accounts advised by Brandes, with the Brandes Small Cap Value Fund …
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy?
Alpha Tau Medical (DRTS) reported a significant widening of its net loss to US$68.75 million in the first half of 2026, up from US$18.81 million a year prior, leading to increased concerns about its funding risk. Despite the company's focus on clinical progress for …
Why Shares of Trump Media & Technology Stock Sank 18% This Week
Shares of Trump Media & Technology (NASDAQ: DJT) fell 18.1% this week, according to data from S&P Global Market Intelligence. The holding company for the Trump family media businesses reported earnings earlier this week, posting large losses on its cryptocurrency assets as it searches …
Solas Capital discloses 9.99% Modular Medical (MODD) position via stock and warrants
Solas Capital Management, LLC and Frederick Tucker Golden have reported an amended beneficial ownership of 9.99% in Modular Medical, Inc. (MODD). This stake comprises 552,171 shares, including common stock and shares issuable upon warrant exercise, with shared voting and dispositive power. The filing details …
ICU Medical (ICUI) Insider Sells 5,417 Shares: VP, GM-Infusion Capital Daniel Woolson Reduces Stake
Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc (ICUI), sold 5,417 shares of the company on August 13, 2026, bringing his total ownership to 17,062 shares. This transaction is part of a trend where insiders at ICU Medical have generally been selling more …